BACKGROUND: Torque Teno virus (TTV) is a ubiquitous infectious agent. Transplant recipients are at risk of hepatitis E virus (HEV) infection and could be vulnerable to TTV-associated adverse effects. The aim of this study was to evaluate the influence of immunosuppression and HEV infection on TTV replication and liver injury in pediatric patients after orthotopic liver transplantation (OLT). METHODS: Pediatric recipients of liver transplants were classified into the following 2 groups: (1) those with normal serum aminotransferases levels and (2) those with persistently increased serum aminotransferases levels and histological features of chronic hepatitis of unknown etiology. The TTV load was assessed in 342 serum samples by use of TaqMan real-time polymerase chain reaction, along with TTV genogroups and coinfection with HEV. RESULTS: TTV DNA was detected in 96% of tested serum samples. Viral load was significantly lower in patients with features of chronic hepatitis, of whom 78% had liver fibrosis scores of ≥2. Viral load decreased during posttransplantation follow-up. Viral load and genogroups were influenced by immunosuppression. Lower viral load was observed in patients coinfected with HEV. CONCLUSIONS: TTV infection is widespread, and its replication is closely related to immune status and viral coinfection. High TTV viremia is not associated with hepatitis after OLT, but, conversely, liver inflammatory activity impairs TTV replication.
BACKGROUND:Torque Teno virus (TTV) is a ubiquitous infectious agent. Transplant recipients are at risk of hepatitis E virus (HEV) infection and could be vulnerable to TTV-associated adverse effects. The aim of this study was to evaluate the influence of immunosuppression and HEVinfection on TTV replication and liver injury in pediatric patients after orthotopic liver transplantation (OLT). METHODS: Pediatric recipients of liver transplants were classified into the following 2 groups: (1) those with normal serum aminotransferases levels and (2) those with persistently increased serum aminotransferases levels and histological features of chronic hepatitis of unknown etiology. The TTV load was assessed in 342 serum samples by use of TaqMan real-time polymerase chain reaction, along with TTV genogroups and coinfection with HEV. RESULTS:TTV DNA was detected in 96% of tested serum samples. Viral load was significantly lower in patients with features of chronic hepatitis, of whom 78% had liver fibrosis scores of ≥2. Viral load decreased during posttransplantation follow-up. Viral load and genogroups were influenced by immunosuppression. Lower viral load was observed in patients coinfected with HEV. CONCLUSIONS:TTVinfection is widespread, and its replication is closely related to immune status and viral coinfection. High TTVviremia is not associated with hepatitis after OLT, but, conversely, liver inflammatory activity impairs TTV replication.
Authors: E Albert; C Solano; E Giménez; D Focosi; A Pérez; L Macera; J L Piñana; J C H Boluda; F Maggi; D Navarro Journal: Bone Marrow Transplant Date: 2017-10-30 Impact factor: 5.483
Authors: Joshua A Blatter; Stuart C Sweet; Carol Conrad; Lara A Danziger-Isakov; Albert Faro; Samuel B Goldfarb; Don Hayes; Ernestina Melicoff; Marc Schecter; Gregory Storch; Gary A Visner; Nikki M Williams; David Wang Journal: Pediatr Transplant Date: 2017-10-29
Authors: Eliseo Albert; Carlos Solano; Estela Giménez; Daniele Focosi; Ariadna Pérez; Lisa Macera; José Luis Piñana; Eva María Mateo; Juan Carlos Hernández Boluda; Fabrizio Maggi; David Navarro Journal: Med Microbiol Immunol Date: 2019-03-09 Impact factor: 3.402
Authors: Efrem S Lim; Yanjiao Zhou; Guoyan Zhao; Irma K Bauer; Lindsay Droit; I Malick Ndao; Barbara B Warner; Phillip I Tarr; David Wang; Lori R Holtz Journal: Nat Med Date: 2015-09-14 Impact factor: 53.440
Authors: Cecilia S Lee; Bryan Hong; Sundeep K Kasi; Christopher Aderman; Katherine E Talcott; Murtaza K Adam; Bryan Yue; Lakshmi Akileswaran; Kenji Nakamichi; Yue Wu; Kasra A Rezaei; Lisa C Olmos de Koo; Yewlin E Chee; Aaron Y Lee; Sunir J Garg; Russell N Van Gelder Journal: Am J Ophthalmol Date: 2020-03-23 Impact factor: 5.258
Authors: A Fuchs; N Lübke; L Schmidt; B-E O Jensen; A Walker; V Keitel-Anselmino; V di Cristanziano; M Böhm; E Knops; E Heger; R Kaiser; A de Luca; M Oette; D Häussinger; J Timm Journal: Infection Date: 2021-02-03 Impact factor: 3.553
Authors: Martin Schiemann; Elisabeth Puchhammer-Stöckl; Farsad Eskandary; Philip Kohlbeck; Susanne Rasoul-Rockenschaub; Andreas Heilos; Nicolas Kozakowski; Irene Görzer; Željko Kikić; Harald Herkner; Georg A Böhmig; Gregor Bond Journal: Transplantation Date: 2017-02 Impact factor: 4.939